← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2015-04-28

Drug application

FDA Application #

ANDA202102

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2015-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown